Question explored with the scientific record
Started from a private conversation ↓
Will iron infusion also help with fatigue and low energy
The short version: IV iron can help fatigue and low energy, but the evidence for that specific outcome is thinner than the evidence for restless legs, and your ferritin of 55 sits in a gray zone.
The strongest evidence in this retrieval for IV iron helping fatigue comes from studies where people were actually anemic. In pregnant women with iron deficiency anemia, IV iron raised hemoglobin faster and higher than oral iron, and about 92% resolved their anemia by delivery [6, 7]. In chronic kidney disease patients with anemia, IV iron beat oral iron on hemoglobin, ferritin, and transferrin saturation over 12 weeks [5]. A 2013 trial in anemic patients who failed oral iron found IV iron raised hemoglobin by about 1.6 g/dL versus 0.8 for oral iron [4]. The pattern is consistent: when you are anemic, IV iron corrects the blood counts faster and more completely.
But you are not anemic. Your ferritin is 55, which is low for restless legs but not the classic anemic range. The retrieval has no trial that directly measures fatigue or energy in non-anemic people with ferritin around 55. The closest is the restless legs literature, where IV iron is first-line when ferritin is below 100 [8], and a 2025 case report showed dramatic sleep and developmental improvement in a child after IV iron [2]. Better sleep can absolutely translate into better daytime energy. That is a real mechanism, but it is indirect.
The safety picture matters here. A 2015 meta-analysis of 103 trials found no overall increase in serious adverse events with IV iron, but infusion reactions were about 2.5 times more common, with a number-needed-to-harm of roughly 292 [3]. Ferric carboxymaltose had a risk ratio for serious events of 0.82, trending safer than comparators [3]. A 2018 cohort found ferric carboxymaltose had a 2.1% hypersensitivity rate versus 8.7% for iron isomaltoside [1]. A 2026 mouse study found a single IV iron dose triggered ferroptosis-like lipid damage in a heart failure model [9]. That is animal data, but it is a signal that IV iron is not metabolically inert.
The honest answer: IV iron will likely help your restless legs, and if your sleep improves, your energy may follow. But if you are hoping for a direct fatigue fix at ferritin 55, the evidence is not there. The studies that show fatigue benefit are all in anemic populations.
My call: IV iron is reasonable for your restless legs and may improve energy through better sleep, but do not expect a guaranteed fatigue cure at ferritin 55. Confidence: moderate for restless legs, low for direct fatigue benefit.
Sources used 9
-
Comparison of hypersensitivity reactions of intravenous iron: iron isomaltoside‐1000 (Monofer ® ) versus ferric carboxy‐maltose (Ferinject ® ). A single center, cohort study
A real-world, single-center cohort study comparing hypersensitivity reaction risk during intravenous iron infusions found ferric carboxymaltose to be associated with a substantially lower risk than iron isomaltoside-1000, with comorbidity and younger age also increasing risk.
DOI: 10.1111/bcp.13805 -
1480 Restless Sleep Disorder in a Child with Autism Spectrum Disorder: Response to Intravenous Iron Therapy
This case report describes a 3-year-old boy with non-verbal autism and restless sleep disorder due to iron deficiency who experienced dramatic improvement in sleep and developmental functioning after three intravenous iron sucrose infusions, following failure of oral iron therap…
DOI: 10.1093/sleep/zsaf090.1480 -
The Safety of Intravenous Iron Preparations
A comprehensive systematic review and meta-analysis of 103 randomized trials (10,390 IV iron-treated vs various controls) showing intravenous iron does not increase serious adverse events or infections overall, though infusion reactions are more common with some formulations; fe…
DOI: 10.1016/j.mayocp.2014.10.007 -
A multicenter, randomized, active‐controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia
Ferric carboxymaltose given as two 750-mg intravenous infusions significantly increases hemoglobin compared with oral iron in iron deficiency anemia patients who had an inadequate response to or intolerance of oral iron, with safety comparable to intravenous standard-of-care iro…
DOI: 10.1111/trf.12289 -
Comparative Study of Oral vs. Intravenous Iron Supplements in the Management of Anemia in Chronic Kidney Disease
A randomized prospective trial in CKD patients with anemia found intravenous iron sucrose superior to oral ferrous sulfate in increasing hemoglobin, ferritin, and transferrin saturation over 12 weeks, with fewer gastrointestinal side effects but more infusion reactions.
DOI: 10.52783/jns.v14.3247 -
Safety and efficacy of rapid (1,000 mg in 1 hr) intravenous iron dextran for treatment of maternal iron deficient anemia of pregnancy
A retrospective observational study showing that a single 1,000 mg rapid infusion of low molecular weight iron dextran is safe and effective for treating moderate-to-severe iron deficiency anemia in pregnancy, significantly increasing hemoglobin with minimal adverse events and h…
DOI: 10.1002/ajh.24361 -
More Effective Route of Treatment for Iron Deficiency Anemia in Pregnancy Intravenous Vs Oral Iron
A systematic literature review comparing intravenous versus oral iron for iron deficiency anemia in pregnancy, finding IV iron provides faster and greater correction of hemoglobin and iron stores with better maternal tolerance and outcomes, though cost and infusion consideration…
DOI: 10.1182/blood-2024-201765 -
Comorbidities, treatment, and pathophysiology in restless legs syndrome
This 2018 Lancet Neurology Review synthesizes current understanding of restless legs syndrome (Willis-Ekbom disease) focusing on comorbidities, treatment strategies (with emphasis on augmentation risk from dopaminergic therapies and iron-based options), pathophysiology (brain ir…
DOI: 10.1016/S1474-4422(18)30311-9 -
A single dose of intravenous iron induces cardiac ferroptosis in murine cardiometabolic heart failure
A single intravenous iron dose triggers ferroptosis-like lipid damage and worsens cardiac parameters in a mouse model of cardiometabolic heart failure with preserved ejection fraction (HFpEF).
DOI: 10.1172/jci.insight.195410